hanscasteels, somatic testing of the tumor yields information about the value of ADT for each individual. All prostate patients should consider Decipher or other testing for tumor mutations before taking ADT. Weight gain is more a consideration against ADT in patients who are obese and if they have more advanced cancer.
The effect of ADT on a tumor is dramatic. It can halve the size of the tumor within five months and quarter the PSA. Weigh gain is slower and with low carb diets are advised.
Clinical trial are why ADT is so commonly advised.
The consequence of weight gain is a much more improtant contributor to cell grow than sugar.
Drug interactions between Ozympic and ADT have not been found. There are other side effect with Ozymic alone that should be considered.
You may decide against ADT when you are clear about your own risks and advantages. It really is not a fun choice to to need to make. And you may decide to take ADT for several months before treatment and a month or so after. Bless your choice with luck.